| Application no. and date | 14761460.6 (espacenet) (Federated) (European Patent Register), 20140818 | | Patent/reg. no. and date | DK/EP 3036256, 20201028 | | Publication date | 20160629 | | Priority no. and date | US 201361867976 P, 20130820 | | EP pub. no. and date |
EP 3036256 20160629 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rahway, New Jersey 07065, US | | Applicant ref. no. | V156080DK | | Inventor | GU, Danling, 901 S. California Avenue
Palo Alto, California 94304, US,
BEEBE, Amy M., 901 S. California Avenue
Palo Alto, California 94304, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | MODULATION AF TUMORIMMUNITET | | Int. application no. | US2014051402 | | Int. publication no. | WO2015026684 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
